CLINICAL_TRIALS
trial_result
· 2018-09-19
Clinical Trial Update: Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B [Phase 1, Phase 2]
Summary
Clinical trial comparing Myrcludex B to Entecavir in HBeAg-negative chronic hepatitis B has completed phases 1 and 2 with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hepatera Ltd. | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-09-19